Betamethasone dipropionate
| Clinical data | |
|---|---|
| Trade names | Diprolene, Sernivo, Diprosone, others | 
| Other names | Betamethasone-17,21-dipropionate | 
| AHFS/Drugs.com | Monograph | 
| MedlinePlus | a682799 | 
| License data | |
| Pregnancy category  | 
  | 
| Routes of administration  | Topical | 
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
  | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.024.551 | 
| Chemical and physical data | |
| Formula | C28H37FO7 | 
| Molar mass | 504.595 g·mol−1 | 
| 3D model (JSmol) | |
  | |
  | |
| (what is this?) (verify) | |
Betamethasone dipropionate is a glucocorticoid steroid with anti-inflammatory and immunosuppressive properties. It is applied as a topical cream, ointment, lotion or gel (Diprolene) to treat itching and other skin conditions such as eczema. Minor side effects include dry skin and mild, temporary stinging when applied. Betamethasone dipropionate is a "super high potency" corticosteroid used to treat inflammatory skin conditions such as dermatitis, eczema and psoriasis. It is a synthetic analog of the adrenal corticosteroids. Although its exact mechanism of action is not known, it is effective when applied topically to cortico-responsive inflammatory dermatoses. It is available as a generic medication.